Argos Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Argos Wealth Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$704K	Hold	11,600	–	–	0.2%	55
2025 Q4	$626K	Buy	+11,600	New	+$558K	0.17%	72

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Argos Wealth Advisors's BMY Position: Q1 2026 in Review

Argos Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 11,600 shares worth $704K. The position accounts for 0.2% of the portfolio, ranked #55.

Argos Wealth Advisors first reported a position in BMY in Q4 2025 and has held it in 2 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Argos Wealth Advisors held 11,600 shares of Bristol-Myers Squibb worth $704K as of Q1 2026.
Argos Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
Bristol-Myers Squibb made up 0.2% of Argos Wealth Advisors's portfolio in Q1 2026, its #55 holding.
Argos Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 2 quarters since.
2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Argos Wealth Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.